Eric Topol talks with New Yorker columnist and best-selling author Malcolm Gladwell on how best to tell the story of medicine.

Experts take on the issue of value in cancer care -- among the hottest topics of ASCO 2015 -- and what is at stake if efforts to ensure value do not succeed in containing healthcare costs.

Paul A. Offit, MD, describes new research on a vaccine for shingles that could be a great step forward.

Dr David Johnson explains why he does not share the news media's concern about proton pump inhibitors and cardiovascular risk.

Dr Jeffrey Berns reminds clinicians to be vigilant about the medications their patients take, both prescription and over-the-counter.

When the Antibiotic Resistance National Action Plan was announced, our readers had many concerns and questions. We asked CDC Director Tom Frieden for answers.

Occult magnesium deficiency may be responsible for innumerable ailments, but plasma and serum levels are unreliable measures. Dr Lundberg offers his advice for addressing this important problem.

Multiple studies presented at this year's American Academy of Neurology Annual meeting showed encouraging results for MS patients (and some did not).

By fall, there may be two new drugs in the lipid-lowering toolbox. Seth Bilazarian quizzes Marc Sabatine about what this means for the lipid landscape and the use of a genetic risk score.

Dr Silvio Inzucchi describes the ongoing quest to determine whether any diabetes medications might help lower cardiovascular risks.